학술논문
Umbralisib, a PI3K delta/CK1 epsilon Dual Inhibitor Demonstrates Marked Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (iNHL): Results from the Phase 2 Global UNITY-NHL Trial
Document Type
Journal
Author
Ghosh, Nilanjan; Zinzani, Pier Luigi; Samaniego, Felipe; Jurczak, Wojciech; Derenzini, Enrico; Reeves, James A.; Knopinska-Posluszny, Wanda; Cheah, Chan Y.; Phillips, Tycel; Lech-Maranda, Ewa; Cheson, Bruce; Caimi, Paolo; Grosicki, Sebastian; Leslie, Lori A.; Chavez, Julio C.; Fonseca, Gustavo; Babu, Sunil; Hodson, Daniel J.; Shao, Spencer H.; Burke, John M.; Sharman, Jeff P.; Law, Jennie Y.; Pagel, John M.; Miskin, Hari P.; Sportelli, Peter; O'Connor, Owen A.; Weiss, Michael S.; Fowler, Nathan H.
Source
Subject
Language
English
ISSN
21522669